Johnson & Johnson Eyes Protagonist: Biotech Buyout?

Johnson & Johnson eyes Protagonist Therapeutics! Shares surge as acquisition talks begin. What does this mean for the future of biotech and your investments? Tune in for the latest updates on this developing story. Hosted on Acast. See acast.com/privacy for more information.